FPR2 and triple-A syndrome: PRLMs demonstrate substantial protective potential in AAA by suppressing proinflammatory signaling, modulating immune cell polarization, and fine-tuning the vascular immune microenvironment through receptor pathways such as ALX-FPR2 and LGR6.